ATLAS Trial: ‘Carryover’ Effect of Tamoxifen Extends to 15 Years Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:3-4, February 10th, 2013. Favorites PDF Get Content & Permissions
Postmenopausal Patients: Letrozole Benefit Varies by Histology and ER-Subtype Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:4-5, February 10th, 2013. Favorites PDF Get Content & Permissions
Kathy Albain on the Significance of ATLAS & BIG for Early/Late Tamoxifen Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:5-6, February 10th, 2013. Favorites PDF Get Content & Permissions
A New Take on ‘Chemo Brain’ Susman, Ed Susman, Ed Less Oncology Times. 35:6, February 10th, 2013. Favorites PDF Get Content & Permissions
Key Takeaways Related to HER2 Therapy Gradishar, William Gradishar, William Less Oncology Times. 35:7-8, February 10th, 2013. Favorites PDF Get Content & Permissions
How the Evolving Link Between Science and Advocacy at SABCS has Grown Even Stronger Rosenthal, Eric T. Rosenthal, Eric T. Less Oncology Times. 35:8-9, February 10th, 2013. Favorites PDF Get Content & Permissions
Black Patients Less Likely to Receive Sentinel Lymph Node Biopsy, Increasing Lymphedema Risk DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 35:10-11, February 10th, 2013. Favorites PDF Get Content & Permissions
BOLERO-2 Study: Everolimus-Exemestane Overcomes Al Resistance Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:11-12, February 10th, 2013. Favorites PDF Get Content & Permissions
Key Takeaways about Metastatic Triple-Negative Breast Cancer Morikawa, Aki Morikawa, Aki Less Oncology Times. 35:12-13, February 10th, 2013. Favorites PDF Get Content & Permissions
Vitamin D Levels Predict Relapse in Early Breast Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:13, February 10th, 2013. Favorites PDF Get Content & Permissions
Metformin Excitement Slows Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:20, February 10th, 2013. Favorites PDF Get Content & Permissions
Key Takeaways about Hormonal Therapy for Metastatic Breast Cancer O'regan, Ruth O'regan, Ruth Less Oncology Times. 35:21-22, February 10th, 2013. Favorites PDF Get Content & Permissions
CONFIRM Trial: Confirmation of Clinical Experience that Higher-Dose Fulvestrant is Better than Lower Doses in Advanced ER+ Breast Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:22, February 10th, 2013. Favorites PDF Get Content & Permissions
Key Takeaways about Breast Cancer Biology: Better Therapy Promised for Triple-Negative Breast Cancer Ma, Cynthia X. Ma, Cynthia X. Less Oncology Times. 35:23-24, February 10th, 2013. Favorites PDF Get Content & Permissions
Metastatic Breast Cancer: PD 0332991 + Letrozole Triples PFS Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:24-25, February 10th, 2013. Favorites PDF Get Content & Permissions
Neoadjuvant Chemotherapy Shown to Benefit Many Younger Women with Breast Cancer Laino, Charlene Laino, Charlene Less Oncology Times. 35:25, February 10th, 2013. Favorites PDF Get Content & Permissions
MUSINGS OF A CANCER DOCTOR: Taking Off from San Antonio Sledge, George W. Sledge, George W. Less Oncology Times. 35:26-27, February 10th, 2013. Favorites PDF Get Content & Permissions
Routine MRI Use Not Recommended in Managing Breast Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:27, February 10th, 2013. Favorites PDF Get Content & Permissions
